rs3765687
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002867.4(RAB3B):c.347+860C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.526 in 151,998 control chromosomes in the GnomAD database, including 22,234 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.53 ( 22234 hom., cov: 32)
Consequence
RAB3B
NM_002867.4 intron
NM_002867.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0510
Publications
1 publications found
Genes affected
RAB3B (HGNC:9778): (RAB3B, member RAS oncogene family) Enables GDP binding activity; GTPase activity; and myosin V binding activity. Involved in several processes, including positive regulation of dopamine uptake involved in synaptic transmission; regulation of synaptic vesicle cycle; and regulation of vesicle size. Located in perinuclear region of cytoplasm and vesicle. Is active in dopaminergic synapse. Is anchored component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.832 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.526 AC: 79908AN: 151880Hom.: 22217 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
79908
AN:
151880
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.526 AC: 79945AN: 151998Hom.: 22234 Cov.: 32 AF XY: 0.528 AC XY: 39248AN XY: 74284 show subpopulations
GnomAD4 genome
AF:
AC:
79945
AN:
151998
Hom.:
Cov.:
32
AF XY:
AC XY:
39248
AN XY:
74284
show subpopulations
African (AFR)
AF:
AC:
14152
AN:
41442
American (AMR)
AF:
AC:
9473
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2094
AN:
3466
East Asian (EAS)
AF:
AC:
4423
AN:
5184
South Asian (SAS)
AF:
AC:
2506
AN:
4824
European-Finnish (FIN)
AF:
AC:
5998
AN:
10550
Middle Eastern (MID)
AF:
AC:
169
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39386
AN:
67942
Other (OTH)
AF:
AC:
1197
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1840
3681
5521
7362
9202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2318
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.